Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B9e2f7b0e4ec651ef4db23a16ab0ef7c5> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B9e2f7b0e4ec651ef4db23a16ab0ef7c5 NCIT_P378 "NCI" @default.
- B9e2f7b0e4ec651ef4db23a16ab0ef7c5 type Axiom @default.
- B9e2f7b0e4ec651ef4db23a16ab0ef7c5 annotatedProperty IAO_0000115 @default.
- B9e2f7b0e4ec651ef4db23a16ab0ef7c5 annotatedSource NCIT_C181801 @default.
- B9e2f7b0e4ec651ef4db23a16ab0ef7c5 annotatedTarget "A chemoimmunotherapy regimen consisting of paclitaxel and pembrolizumab that can be used for the treatment of recurrent and metastatic hormone receptor-negative, HER-2 (EGFR2; ErbB2)-negative and PD-L1-positive breast cancer." @default.